Shanxi Zhendong Pharmaceutical Co.,Ltd (SHE:300158)
China · Delayed Price · Currency is CNY 8.68
-0.13 (-1.48%)
Aug 28, 2025, 1:45 PM CST
SHE:300158 Revenue
Shanxi Zhendong Pharmaceutical Co.,Ltd had revenue of 702.41M CNY in the quarter ending June 30, 2025, a decrease of -3.05%. This brings the company's revenue in the last twelve months to 2.92B, down -8.70% year-over-year. In the year 2024, Shanxi Zhendong Pharmaceutical Co.,Ltd had annual revenue of 2.97B, down -18.06%.
Revenue (ttm)
2.92B
Revenue Growth
-8.70%
P/S Ratio
3.00
Revenue / Employee
785.34K
Employees
3,720
Market Cap
8.77B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 2.97B | -654.89M | -18.06% |
| Dec 31, 2023 | 3.63B | -102.54M | -2.75% |
| Jan 1, 2023 | 3.73B | -1.37B | -26.80% |
| Jan 1, 2022 | 5.09B | 245.94M | 5.07% |
| Dec 31, 2020 | 4.85B | 449.08M | 10.21% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Jiangsu Hengrui Medicine | 30.15B |
| Shenzhen Mindray Bio-Medical Electronics | 35.59B |
| WuXi AppTec | 41.90B |
| Sichuan Biokin Pharmaceutical | 441.19M |
| Zhangzhou Pientzehuang Pharmaceutical., | 10.52B |
| Aier Eye Hospital Group | 21.81B |
| Shanghai United Imaging Healthcare | 10.43B |
| Yunnan Baiyao Group Co.,Ltd | 40.10B |